. 2007 Mar 6;8(1):19. doi: 10.1186/1465-9921-8-19

Table 2.

Results of the high dose salbutamol study (study 1)

Treatment	Placebo	Formoterol
Pre-challenge FEV₁(L) (SD)	2.55 (0.75)	2.57 (0.72)
Post challenge FEV₁(L) (SD)	1.92 (0.59)	2.00 (0.51)
PD₂₀methacholine (mg) (geometric mean, 95% CI)	0.08 (0.03, 0.22)	0.10 (0.04, 0.25)

AUC salbutamol (%.time) (SD)	412 (140)	339 (201)
Difference: paired t-test (95% CI)	73 (-4, 149) p = 0.06
Difference: covariate analysis (placebo-formoterol) (least squares means, 95% CI)	63 (22, 105) p = 0.008

Post-salbutamol FEV₁at 20 mins (L) (SD)	2.79 (0.86)	2.67 (0.84)
Difference: paired t-test (95% CI)	0.12 (0.03, 0.20) p = 0.008
Difference: covariate analysis (placebo-formoterol) (least squares means, 95% CI)	0.12 (0.06, 0.19) p = 0.003